Sun Pharma Settles Patent Dispute with Incyte, Secures License for Leqselvi Launch

Unknown Apr 02, 2026 850 Views

Sun Pharmaceutical Industries has reached a settlement with Incyte Corporation over the disputed launch of Leqselvi, its alopecia areata treatment, in the United States. The agreement includes an upfront payment and ongoing royalties in exchange for a nonexclusive license to U.S. Patent No. 9,662...